FDA Import Refusal SCS-3028928-5/11/1 — Astellas Pharma Inc
The FDA refused shipment SCS-3028928-5/11/1 from Astellas Pharma Inc (Japan) on February 20, 2019. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- February 20, 2019
- Country
- Japan
- Product Category
- Drugs and Biologics
- Product Code
- 66VCS99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75